Craving

Craving is an intense, often intrusive urge to use a substance — distinct from simple desire in that it can arise involuntarily, persist despite negative consequences, and override competing intentions. It is considered one of the defining features of addiction and a primary driver of relapse during and after attempts to stop using.

The experience is both psychological and physical: it involves conscious want, but also automatic responses in the brain that can be triggered by cues — people, places, objects, or emotions associated with past use. This cue-driven quality is what makes craving particularly difficult to manage through willpower alone.

How it works · its role

Craving is thought to arise largely from changes in the brain's dopamine-driven reward circuitry, particularly in a region called the nucleus accumbens. Repeated substance use alters this system so that cues associated with the drug come to activate strong anticipatory signals — the brain predicts reward and generates an urge accordingly.

At the same time, the prefrontal cortex, which ordinarily helps regulate impulse, becomes less effective at inhibiting these signals in people with established dependence. The result is an imbalance: the drive toward the substance is amplified while the braking mechanism is weakened.

Stress hormones and the brain's stress circuitry — particularly involving corticotropin-releasing factor — also feed into craving, which is why emotional distress is a common trigger.

Relevance to substances & effects

Craving is most prominent with substances that strongly engage the dopamine reward system. Stimulants such as cocaine and amphetamines produce intense, acute craving that can persist for months into abstinence. Opioids and alcohol are associated with craving driven by both reward anticipation and the desire to relieve withdrawal discomfort.

Nicotine craving is notable for its speed and sensitivity to environmental cues — even briefly seeing a familiar smoking context can trigger a strong urge. Cannabis craving, while often described as milder, is increasingly recognised as clinically significant in heavy users.

Some psychedelics and entactogens can transiently blunt craving — this is an area of active research — though they are not themselves strongly associated with craving in the classical sense.

Tolerance & dependence

Craving and dependence are closely linked but not identical. A person can experience significant craving without meeting clinical criteria for dependence, and the intensity of craving does not always track with the severity of physical withdrawal.

Over time, cue-associated craving can be conditioned deeply enough that it persists long after the drug has cleared the body and acute withdrawal has resolved — sometimes for years. This is why relapse rates remain elevated well into recovery, and why environmental change and behavioural therapies targeting cue reactivity are considered important components of sustained recovery alongside any pharmacological support.